0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Eye Injection Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-38O16448
Home | Market Reports | Health| Vision Care
Global Eye Injection Market Research Report 2024
BUY CHAPTERS

Global Eye Injection Market Research Report 2025

Code: QYRE-Auto-38O16448
Report
September 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Eye Injection Market

The global market for Eye Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Eye Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Eye Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Eye Injection include Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio, Regeneron, Roche, Fagron, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Eye Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eye Injection.
The Eye Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Eye Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eye Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Eye Injection Market Report

Report Metric Details
Report Name Eye Injection Market
Segment by Type
  • Ranibizumab
  • Bevacizumab
  • Aflibercept
  • Brolucizumab
  • Faricimab
  • Others
Segment by Application
  • Age-related Macular Degeneration (AMD)
  • Diabetic Retinopathy
  • Retinal Vein Occlusion (RVO)
  • Retinopathy of Prematurity (ROP)
  • Uveitis
  • Neovascular Glaucoma
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio, Regeneron, Roche, Fagron, Qilu Pharmaceutical Co.,Ltd., Chengdu Kanghong Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Eye Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Eye Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Eye Injection Market report?

Ans: The main players in the Eye Injection Market are Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio, Regeneron, Roche, Fagron, Qilu Pharmaceutical Co.,Ltd., Chengdu Kanghong Pharmaceutical Group

What are the Application segmentation covered in the Eye Injection Market report?

Ans: The Applications covered in the Eye Injection Market report are Age-related Macular Degeneration (AMD), Diabetic Retinopathy, Retinal Vein Occlusion (RVO), Retinopathy of Prematurity (ROP), Uveitis, Neovascular Glaucoma, Others

What are the Type segmentation covered in the Eye Injection Market report?

Ans: The Types covered in the Eye Injection Market report are Ranibizumab, Bevacizumab, Aflibercept, Brolucizumab, Faricimab, Others

1 Eye Injection Market Overview
1.1 Product Definition
1.2 Eye Injection by Type
1.2.1 Global Eye Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Ranibizumab
1.2.3 Bevacizumab
1.2.4 Aflibercept
1.2.5 Brolucizumab
1.2.6 Faricimab
1.2.7 Others
1.3 Eye Injection by Application
1.3.1 Global Eye Injection Market Value by Application (2024 VS 2031)
1.3.2 Age-related Macular Degeneration (AMD)
1.3.3 Diabetic Retinopathy
1.3.4 Retinal Vein Occlusion (RVO)
1.3.5 Retinopathy of Prematurity (ROP)
1.3.6 Uveitis
1.3.7 Neovascular Glaucoma
1.3.8 Others
1.4 Global Eye Injection Market Size Estimates and Forecasts
1.4.1 Global Eye Injection Revenue 2020-2031
1.4.2 Global Eye Injection Sales 2020-2031
1.4.3 Global Eye Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Eye Injection Market Competition by Manufacturers
2.1 Global Eye Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Eye Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Eye Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Eye Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eye Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eye Injection, Product Type & Application
2.7 Global Key Manufacturers of Eye Injection, Date of Enter into This Industry
2.8 Global Eye Injection Market Competitive Situation and Trends
2.8.1 Global Eye Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Eye Injection Players Market Share by Revenue
2.8.3 Global Eye Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Eye Injection Market Scenario by Region
3.1 Global Eye Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Eye Injection Sales by Region: 2020-2031
3.2.1 Global Eye Injection Sales by Region: 2020-2025
3.2.2 Global Eye Injection Sales by Region: 2026-2031
3.3 Global Eye Injection Revenue by Region: 2020-2031
3.3.1 Global Eye Injection Revenue by Region: 2020-2025
3.3.2 Global Eye Injection Revenue by Region: 2026-2031
3.4 North America Eye Injection Market Facts & Figures by Country
3.4.1 North America Eye Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Eye Injection Sales by Country (2020-2031)
3.4.3 North America Eye Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Eye Injection Market Facts & Figures by Country
3.5.1 Europe Eye Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Eye Injection Sales by Country (2020-2031)
3.5.3 Europe Eye Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eye Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Eye Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Eye Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Eye Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Eye Injection Market Facts & Figures by Country
3.7.1 Latin America Eye Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Eye Injection Sales by Country (2020-2031)
3.7.3 Latin America Eye Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Eye Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Eye Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Eye Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Eye Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eye Injection Sales by Type (2020-2031)
4.1.1 Global Eye Injection Sales by Type (2020-2025)
4.1.2 Global Eye Injection Sales by Type (2026-2031)
4.1.3 Global Eye Injection Sales Market Share by Type (2020-2031)
4.2 Global Eye Injection Revenue by Type (2020-2031)
4.2.1 Global Eye Injection Revenue by Type (2020-2025)
4.2.2 Global Eye Injection Revenue by Type (2026-2031)
4.2.3 Global Eye Injection Revenue Market Share by Type (2020-2031)
4.3 Global Eye Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Eye Injection Sales by Application (2020-2031)
5.1.1 Global Eye Injection Sales by Application (2020-2025)
5.1.2 Global Eye Injection Sales by Application (2026-2031)
5.1.3 Global Eye Injection Sales Market Share by Application (2020-2031)
5.2 Global Eye Injection Revenue by Application (2020-2031)
5.2.1 Global Eye Injection Revenue by Application (2020-2025)
5.2.2 Global Eye Injection Revenue by Application (2026-2031)
5.2.3 Global Eye Injection Revenue Market Share by Application (2020-2031)
5.3 Global Eye Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Eye Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Eye Injection Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Eye Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Eye Injection Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Eye Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Eye Injection Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Genentech
6.4.1 Genentech Company Information
6.4.2 Genentech Description and Business Overview
6.4.3 Genentech Eye Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Genentech Eye Injection Product Portfolio
6.4.5 Genentech Recent Developments/Updates
6.5 Apellis Pharmaceuticals, Inc.
6.5.1 Apellis Pharmaceuticals, Inc. Company Information
6.5.2 Apellis Pharmaceuticals, Inc. Description and Business Overview
6.5.3 Apellis Pharmaceuticals, Inc. Eye Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Apellis Pharmaceuticals, Inc. Eye Injection Product Portfolio
6.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Coherus BioSciences Inc.
6.6.1 Coherus BioSciences Inc. Company Information
6.6.2 Coherus BioSciences Inc. Description and Business Overview
6.6.3 Coherus BioSciences Inc. Eye Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Coherus BioSciences Inc. Eye Injection Product Portfolio
6.6.5 Coherus BioSciences Inc. Recent Developments/Updates
6.7 Iveric Bio
6.7.1 Iveric Bio Company Information
6.7.2 Iveric Bio Description and Business Overview
6.7.3 Iveric Bio Eye Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Iveric Bio Eye Injection Product Portfolio
6.7.5 Iveric Bio Recent Developments/Updates
6.8 Regeneron
6.8.1 Regeneron Company Information
6.8.2 Regeneron Description and Business Overview
6.8.3 Regeneron Eye Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Regeneron Eye Injection Product Portfolio
6.8.5 Regeneron Recent Developments/Updates
6.9 Roche
6.9.1 Roche Company Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Eye Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Roche Eye Injection Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Fagron
6.10.1 Fagron Company Information
6.10.2 Fagron Description and Business Overview
6.10.3 Fagron Eye Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Fagron Eye Injection Product Portfolio
6.10.5 Fagron Recent Developments/Updates
6.11 Qilu Pharmaceutical Co.,Ltd.
6.11.1 Qilu Pharmaceutical Co.,Ltd. Company Information
6.11.2 Qilu Pharmaceutical Co.,Ltd. Description and Business Overview
6.11.3 Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Qilu Pharmaceutical Co.,Ltd. Eye Injection Product Portfolio
6.11.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.12 Chengdu Kanghong Pharmaceutical Group
6.12.1 Chengdu Kanghong Pharmaceutical Group Company Information
6.12.2 Chengdu Kanghong Pharmaceutical Group Description and Business Overview
6.12.3 Chengdu Kanghong Pharmaceutical Group Eye Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Chengdu Kanghong Pharmaceutical Group Eye Injection Product Portfolio
6.12.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eye Injection Industry Chain Analysis
7.2 Eye Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eye Injection Production Mode & Process Analysis
7.4 Eye Injection Sales and Marketing
7.4.1 Eye Injection Sales Channels
7.4.2 Eye Injection Distributors
7.5 Eye Injection Customer Analysis
8 Eye Injection Market Dynamics
8.1 Eye Injection Industry Trends
8.2 Eye Injection Market Drivers
8.3 Eye Injection Market Challenges
8.4 Eye Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Eye Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Eye Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Eye Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Eye Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Eye Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Eye Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Eye Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Eye Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Eye Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Eye Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Eye Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Eye Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Eye Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Eye Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Eye Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Eye Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Eye Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Eye Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Eye Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Eye Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Eye Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Eye Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Eye Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Eye Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Eye Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Eye Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Eye Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Eye Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Eye Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Eye Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Eye Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Eye Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Eye Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Eye Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Eye Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Eye Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Eye Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Eye Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Eye Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Eye Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Eye Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Eye Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Eye Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Eye Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Eye Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Eye Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Eye Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Eye Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Eye Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Eye Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Eye Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Eye Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Eye Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Eye Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Eye Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Eye Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Eye Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Eye Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Eye Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Eye Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Eye Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Eye Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Eye Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Eye Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Eye Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Eye Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Eye Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Eye Injection Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Novartis Eye Injection Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Bayer Company Information
 Table 81. Bayer Description and Business Overview
 Table 82. Bayer Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bayer Eye Injection Product
 Table 84. Bayer Recent Developments/Updates
 Table 85. Genentech Company Information
 Table 86. Genentech Description and Business Overview
 Table 87. Genentech Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Genentech Eye Injection Product
 Table 89. Genentech Recent Developments/Updates
 Table 90. Apellis Pharmaceuticals, Inc. Company Information
 Table 91. Apellis Pharmaceuticals, Inc. Description and Business Overview
 Table 92. Apellis Pharmaceuticals, Inc. Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Apellis Pharmaceuticals, Inc. Eye Injection Product
 Table 94. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
 Table 95. Coherus BioSciences Inc. Company Information
 Table 96. Coherus BioSciences Inc. Description and Business Overview
 Table 97. Coherus BioSciences Inc. Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Coherus BioSciences Inc. Eye Injection Product
 Table 99. Coherus BioSciences Inc. Recent Developments/Updates
 Table 100. Iveric Bio Company Information
 Table 101. Iveric Bio Description and Business Overview
 Table 102. Iveric Bio Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Iveric Bio Eye Injection Product
 Table 104. Iveric Bio Recent Developments/Updates
 Table 105. Regeneron Company Information
 Table 106. Regeneron Description and Business Overview
 Table 107. Regeneron Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Regeneron Eye Injection Product
 Table 109. Regeneron Recent Developments/Updates
 Table 110. Roche Company Information
 Table 111. Roche Description and Business Overview
 Table 112. Roche Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Roche Eye Injection Product
 Table 114. Roche Recent Developments/Updates
 Table 115. Fagron Company Information
 Table 116. Fagron Description and Business Overview
 Table 117. Fagron Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Fagron Eye Injection Product
 Table 119. Fagron Recent Developments/Updates
 Table 120. Qilu Pharmaceutical Co.,Ltd. Company Information
 Table 121. Qilu Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 122. Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Qilu Pharmaceutical Co.,Ltd. Eye Injection Product
 Table 124. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 125. Chengdu Kanghong Pharmaceutical Group Company Information
 Table 126. Chengdu Kanghong Pharmaceutical Group Description and Business Overview
 Table 127. Chengdu Kanghong Pharmaceutical Group Eye Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Chengdu Kanghong Pharmaceutical Group Eye Injection Product
 Table 129. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Eye Injection Distributors List
 Table 133. Eye Injection Customers List
 Table 134. Eye Injection Market Trends
 Table 135. Eye Injection Market Drivers
 Table 136. Eye Injection Market Challenges
 Table 137. Eye Injection Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Eye Injection
 Figure 2. Global Eye Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Eye Injection Market Share by Type: 2024 & 2031
 Figure 4. Ranibizumab Product Picture
 Figure 5. Bevacizumab Product Picture
 Figure 6. Aflibercept Product Picture
 Figure 7. Brolucizumab Product Picture
 Figure 8. Faricimab Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Eye Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Eye Injection Market Share by Application: 2024 & 2031
 Figure 12. Age-related Macular Degeneration (AMD)
 Figure 13. Diabetic Retinopathy
 Figure 14. Retinal Vein Occlusion (RVO)
 Figure 15. Retinopathy of Prematurity (ROP)
 Figure 16. Uveitis
 Figure 17. Neovascular Glaucoma
 Figure 18. Others
 Figure 19. Global Eye Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Eye Injection Market Size (2020-2031) & (US$ Million)
 Figure 21. Global Eye Injection Sales (2020-2031) & (K Units)
 Figure 22. Global Eye Injection Average Price (US$/Unit) & (2020-2031)
 Figure 23. Eye Injection Report Years Considered
 Figure 24. Eye Injection Sales Share by Manufacturers in 2024
 Figure 25. Global Eye Injection Revenue Share by Manufacturers in 2024
 Figure 26. Global 5 and 10 Largest Eye Injection Players: Market Share by Revenue in Eye Injection in 2024
 Figure 27. Eye Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 28. Global Eye Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 29. North America Eye Injection Sales Market Share by Country (2020-2031)
 Figure 30. North America Eye Injection Revenue Market Share by Country (2020-2031)
 Figure 31. United States Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Canada Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Europe Eye Injection Sales Market Share by Country (2020-2031)
 Figure 34. Europe Eye Injection Revenue Market Share by Country (2020-2031)
 Figure 35. Germany Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. France Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. U.K. Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Italy Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Russia Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Asia Pacific Eye Injection Sales Market Share by Region (2020-2031)
 Figure 41. Asia Pacific Eye Injection Revenue Market Share by Region (2020-2031)
 Figure 42. China Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Japan Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. South Korea Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. India Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Australia Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. China Taiwan Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Southeast Asia Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Eye Injection Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Eye Injection Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Eye Injection Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Eye Injection Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Eye Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Eye Injection by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Eye Injection by Type (2020-2031)
 Figure 61. Global Eye Injection Price (US$/Unit) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Eye Injection by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Eye Injection by Application (2020-2031)
 Figure 64. Global Eye Injection Price (US$/Unit) by Application (2020-2031)
 Figure 65. Eye Injection Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Single-Port Vitrectomy Cutter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13L12609
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Eye Ultrasound Biomicroscope Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32B20021
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Plano-Convex Laser Lenses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38C19846
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Heated Eye Masks Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2H20253
Thu Nov 27 00:00:00 UTC 2025

Add to Cart